Novel phenotypes identified by plasma biochemical screening in the mouse

Mammalian Genome

Volumn 13, Issue 10, 2002, Pages 595-602

  Hough, Tertius A ^a   Nolan, Patrick M ^a   Tsipouri, Vicky ^b   Toye, Ayo A ^a   Gray, Ian C ^b   Goldsworthy, Michelle ^a   Moir, Lee ^a   Cox, Roger D ^a   Clements, Sian ^a   Glenister, Peter H ^a   Wood, John ^b   Selley, Rachael L ^a   Strivens, Mark A ^a   Vizor, Lucie ^a   McCormack, Stefan L ^a   Peters, Josephine ^a   Fisher, Elizabeth M ^d   Spurr, Nigel ^b   Rastan, Sohaila ^b   Martin, Joanne E ^c   Brown, Steve D M ^a   Jacqueline Hunter, A ^b   more..

^a MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHLORIDE; ELECTROLYTE; ETHYLNITROSOUREA; GLUCOSE; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD CHEMISTRY; BONE METABOLISM; CHEMICAL MUTAGENESIS; DISEASE MODEL; ELECTROLYTE BLOOD LEVEL; FEMALE; GENE FUNCTION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; INHERITANCE; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROGENY; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CHEMISTRY; MOUSE MUTANT; MUTAGENESIS; PLASMA;

ANIMALIA;

ANIMALS; DISEASE MODELS, ANIMAL; ETHYLNITROSOUREA; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTAGENESIS; PHENOTYPE; PLASMA;

EID: 0036800873     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00335-002-2188-1     Document Type: Article

References (25)

1. Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 14, S1-85
2. Balling R, Brown SDM, Hrabe de Angelis M, Justice M, Nadeau J et al. (2000) Great times for mouse genetics: Getting ready for largescale ENU-mutagenesis. Mamm Genome 11, 471
3. Bedell MA, Largaespada DA, Jenkins NA, Copeland NG (1997) Mouse models of human disease. Part II: Recent progress and future directions. Genes Dev 11, 11-43
4. Bode VC, McDonald JD, Guénet JL, Simon D (1988) hph-1: A mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis. Genetics 118, 299-305
5. Brown SDM, Balling R (2001) Systematic approaches to mouse mutagenesis. Curr Opin Genet Dev 11, 268-273
6. Chien KR (1996) Genes and physiology: molecular physiology in genetically engineered animals. J Clin Invest 97, 901-909
7. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA et al. (1998) A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 19, 292-296
8. Gibson F, Walsh J, Mburu P, Varela A, Brown KA et al. (1995) A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 374, 62-64
9. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26, 163-175
10. Hrabe de Angelis MH, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D et al. (2000) Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 25, 444-447
11. Justice MJ (2000) Capitalizing on large-scale mouse mutagenesis screens. Nat Rev Genet 1, 109-115
12. King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M et al. (1997) Positional cloning of the mouse circadian clock gene. Cell 89, 641-653
13. Marshall WJ (1997) Clinical Chemistry. (London: Mosby)
14. Nishina PM, Wang J, Toyofuku W, Kuypers FA, Ishida BY et al. (1993) Atherosclerosis and plasma and liver lipids in nine inbred strains of mice. Lipids 28, 599-605
15. Nolan PM (2000) Generation of mouse mutants as a tool for functional genomics. Pharmacogenomics 1, 243-255
16. Nolan PM, Peters J, Strivens M, Rogers D, Hagan J et al. (2000a) A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse, Nat Genet 25, 440-443
17. Nolan PM, Peters J, Vizor L, Strivens M, Washbourne R et al. (2000b) Implementation of a large-scale ENU mutagenesis program: Towards increasing the mouse mutant resource. Mamm Genome 11, 500-506
18. Paigen B, Plump AS, Rubin EM (1994) The mouse as a model for human cardiovascular disease and hyperlipidemia. Curr Opin Lipidol 5, 258-264
19. Pretsch W (2000) Enzyme-activity mutants in Mus musculus. I. Phenotypic description and genetic characterization of ethylnitrosourea-induced mutations. Mamm Genome 11, 537-542
20. Pretsch W, Merkle S (1990) Glucose phosphate isomerase enzymeactivity mutants in Mus musculus: Genetical and biochemical characterization. Biochem Genet 28, 97-110
21. Pretsch W, Chatterjee B, Favor J, Merkle S, Sandulache R (1998) Molecular, genetic and biochemical characterization of lactate dehydrogenase-A enzyme activity mutations in Mus musculus. Mamm Genome 9, 144-149
22. Quimby FW (1999) The mouse. In: Loeb WF, Quimby FW (eds) The Clinical Chemistry of Laboratory Animals. (London: Taylor & Francis) pp 3-32
23. Rathkolb B, Decker T, Fuchs E, Soewarto D, Fella C et al. (2000) The clinical-chemical screen in the Munich ENU Mouse Mutagenesis Project: Screening for clinically relevant phenotypes. Mamm Genome 11, 543-546
24. Rogers DC, Fisher EM, Brown SDM, Peters J, Hunter AJ et al. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8, 711-713
25. Strivens MA, Selley RL, Greenaway SJ, Hewitt M, Liu X et al. (2000) Informatics for mutagenesis: The design of mutabase-distributed data recording system for animal husbandry, mutagenesis, and phenotypic analysis. Mamm Genome 11, 577-583 www.worldheart.org/intro/catt.asp www.who.int/ncd/dia/databases.htm